141 related articles for article (PubMed ID: 16739659)
21. Central corticotropin-releasing factor (CRF) may attenuate somatic pain sensitivity through involvement of glucocorticoids.
Yarushkina NI; Bagaeva TR; Filaretova LP
J Physiol Pharmacol; 2011 Oct; 62(5):541-8. PubMed ID: 22204802
[TBL] [Abstract][Full Text] [Related]
22. Suckling and salsolinol attenuate responsiveness of the hypothalamic-pituitary-adrenal axis to stress: focus on catecholamines, corticotrophin-releasing hormone, adrenocorticotrophic hormone, cortisol and prolactin secretion in lactating sheep.
Hasiec M; Tomaszewska-Zaremba D; Misztal T
J Neuroendocrinol; 2014 Dec; 26(12):844-52. PubMed ID: 25205344
[TBL] [Abstract][Full Text] [Related]
23. CRH mRNA expression in the hypothalamic paraventricular nucleus is inhibited despite the activation of the hypothalamo-pituitary-adrenal axis during starvation.
Nishiyama M; Makino S; Iwasaki Y; Tanaka Y; Nazarloo HP; Kaneda T; Asaba K; Hashimoto K
Brain Res; 2008 Sep; 1228():107-12. PubMed ID: 18619422
[TBL] [Abstract][Full Text] [Related]
24. Effect of cyclooxygenase inhibitors on the CRH-induced pituitary-adrenocortical activity during crowding stress.
Bugajski J; Gadek-Michalska A; Bugajski AJ
J Physiol Pharmacol; 2003 Mar; 54(1):99-108. PubMed ID: 12674222
[TBL] [Abstract][Full Text] [Related]
25. [The central gray substance of the midbrain: the role of corticosteroids in the analgesic effect].
Iarushkina NI; Bogdanov AI; Filaretov AA
Fiziol Zh SSSR Im I M Sechenova; 1991 Apr; 77(4):83-9. PubMed ID: 1664365
[TBL] [Abstract][Full Text] [Related]
26. Corticotropin releasing hormone and the hypothalamic-pituitary-adrenal axis in the regulation of inflammatory arthritis.
Wilder RL
Agents Actions Suppl; 1993; 41():3-9. PubMed ID: 8317340
[TBL] [Abstract][Full Text] [Related]
27. The effect of pulsatile human corticotropin-releasing hormone administration on the adrenal insufficiency that follows cure of Cushing's disease.
Avgerinos PC; Nieman LK; Oldfield EH; Loughlin T; Barnes KM; Loriaux DL; Cutler GB
J Clin Endocrinol Metab; 1989 May; 68(5):912-6. PubMed ID: 2541160
[TBL] [Abstract][Full Text] [Related]
28. Suppression of hypothalamic-pituitary-adrenal axis responsiveness to stress in a rat model of acute cholestasis.
Swain MG; Patchev V; Vergalla J; Chrousos G; Jones EA
J Clin Invest; 1993 May; 91(5):1903-8. PubMed ID: 8387536
[TBL] [Abstract][Full Text] [Related]
29. Direct evidence that stimulation of neuropeptide Y Y5 receptor activates hypothalamo-pituitary-adrenal axis in conscious rats via both corticotropin-releasing factor- and arginine vasopressin-dependent pathway.
Kakui N; Kitamura K
Endocrinology; 2007 Jun; 148(6):2854-62. PubMed ID: 17363455
[TBL] [Abstract][Full Text] [Related]
30. Hypothalamus-pituitary-adrenal (HPA) axis in physiological and pathological aging brain.
Lombardi G; Merola B; Savastano S; Tommaselli AP; Valentino R; Rossi R; Ghiggi MR; Cataldi M
Acta Neurol (Napoli); 1991 Aug; 13(4):368-73. PubMed ID: 1781312
[No Abstract] [Full Text] [Related]
31. Stimulation of the hypothalamo-pituitary-adrenal axis in the rat by three selective type-4 phosphodiesterase inhibitors: in vitro and in vivo studies.
Kumari M; Cover PO; Poyser RH; Buckingham JC
Br J Pharmacol; 1997 Jun; 121(3):459-68. PubMed ID: 9179387
[TBL] [Abstract][Full Text] [Related]
32. [Role of the Periaqueductal Gray Matter of the Midbrain in Regulation of Somatic Pain Sensitivity During Stress: Participation of Corticotropin-Releasing Factor and Glucocorticoid Hormones].
Yarushkina NI; Filaretova LP
Usp Fiziol Nauk; 2015; 46(3):3-16. PubMed ID: 26506640
[TBL] [Abstract][Full Text] [Related]
33. Role of the paraventricular and ventromedial hypothalamic nuclear areas in the regulation of the pituitary-adrenocortical system.
Filaretov AA; Filaretova LP
Brain Res; 1985 Sep; 342(1):135-40. PubMed ID: 4041804
[TBL] [Abstract][Full Text] [Related]
34. The effect of insulin-induced hypoglycemia on gene expression in the hypothalamic-pituitary-adrenal axis of the rat.
Robinson BG; Mealy K; Wilmore DW; Majzoub JA
Endocrinology; 1992 Feb; 130(2):920-5. PubMed ID: 1310284
[TBL] [Abstract][Full Text] [Related]
35. Physiological and behavioural effects of an intracerebroventricular injection of corticotropin releasing hormone in goats.
Aoyama M; Negishi A; Abe A; Yokoyama R; Ichimaru T; Sugita S
Vet J; 2008 Jul; 177(1):116-23. PubMed ID: 17572122
[TBL] [Abstract][Full Text] [Related]
36. A view on noradrenergic, hypothalamic-pituitary-adrenal axis and extrahypothalamic corticotrophin-releasing factor function in anxiety and affective disorders: the reduced growth hormone response to clonidine.
Coplan JD; Pine DS; Papp LA; Gorman JM
Psychopharmacol Bull; 1997; 33(2):193-204. PubMed ID: 9230631
[No Abstract] [Full Text] [Related]
37. Chronic brain glucocorticoid receptor blockade enhances the rise in circadian and stress-induced pituitary-adrenal activity.
van Haarst AD; Oitzl MS; Workel JO; de Kloet ER
Endocrinology; 1996 Nov; 137(11):4935-43. PubMed ID: 8895366
[TBL] [Abstract][Full Text] [Related]
38. Site of action of acute alcohol administration in stimulating the rat hypothalamic-pituitary-adrenal axis: comparison between the effect of systemic and intracerebroventricular injection of this drug on pituitary and hypothalamic responses.
Lee S; Selvage D; Hansen K; Rivier C
Endocrinology; 2004 Oct; 145(10):4470-9. PubMed ID: 15205375
[TBL] [Abstract][Full Text] [Related]
39. Nitric oxide mediates the interleukin-1beta- and nicotine-induced hypothalamic-pituitary-adrenocortical response during social stress.
Gadek-Michalska A; Bugajski J
J Physiol Pharmacol; 2005 Sep; 56(3):491-503. PubMed ID: 16204770
[TBL] [Abstract][Full Text] [Related]
40. The role of hypothalamo-hypophyseal-adrenocortical system hormones in controlling pain sensitivity.
Yarushkina NI
Neurosci Behav Physiol; 2008 Oct; 38(8):759-66. PubMed ID: 18802775
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
